Dallas, TX – October 28, 2019 -- -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans to issue an update this Wednesday, October 30th, 2019 regarding the recent acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology.  KALY CEO Frederick Ferri commented on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that the interest stems from industry investors recognizing that KALY’s...

read more